Skip to main content

Table 3 Diagnostic yield of endoscopy

From: Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness

Endoscopic findings

N

Inappropriate

Uncertain

Appropriate

No significant findings

261

51 (19.6%)

45 (17.2%)

165 (63.2%)

Clinically-significant findings

112

8 (7.1%)

16 (14.3%)

88 (78.6%)

Reflux esophagitis

44

5 (11.3%)

2 (4.6%)

37 (84.1%)

Erosive gastritis

13

1 (7.7%)

1 (7.7%)

11 (84.6%)

Gastric ulcer

4

0 (0.0%)

0 (0.0%)

4 (100%)

Stomach cancer

2

0 (0.0%)

1 (50%)

1 (50%)

Inflammatory bowel disease

9

0 (0.0%)

4 (44.4%)

5 (55.6%)

Infectious colitis

4

0 (0.0%)

0 (0.0%)

4 (100%)

Adenomatous polyp

20

1 (5.0%)

4 (20.0%)

15 (75.0%)

Colonic cancer

10

0 (0.0%)

2 (20.0%)

8 (80.0%)

Miscellaneous

6

1 (16.7%)

2 (33.3%)

3 (50.0%)

  1. Data are presented as numbers (%). Reflux esophagitis included Los Angeles grade A (N = 22), grade B (N = 11), grade C (N = 3) and grade D (N = 8). Inflammatory bowel disease included Crohn’s disease (N = 4) and ulcerative colitis (N = 5). Miscellaneous included diverticulitis (N = 2), NSAID-induced colitis (N = 2) and unspecified proctitis (N = 2).